Ignite Creation Date:
2025-12-25 @ 12:10 AM
Ignite Modification Date:
2025-12-25 @ 10:10 PM
Study NCT ID:
NCT06972758
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-05-15
First Post:
2025-05-07
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Adjuvant Everolimus in High-Risk Hepatocellular Carcinoma After Curative Resection (SEVERANCE Trial)
Sponsor:
Yonsei University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-07-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2030-07-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2030-07-30
Completion Date Type:
ESTIMATED
First Submit Date:
2025-05-07
First Submit QC Date:
None
Study First Post Date:
2025-05-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-05-14
Last Update Post Date:
2025-05-15
Last Update Post Date Type:
ACTUAL